AI-generated summary
This literature review describes diabetic macular oedema and compares current treatments, including laser, anti-VEGF agents and steroid implants, with a focus on the fluocinolone acetonide implant ILUVIEN. The authors report that the FAME studies and real-world studies support its use in resolving oedema and improving vision and macular anatomy in this patient group.
- Who or what was studied
- Patients with diabetic macular oedema
- Limits stated in the abstract
- The abstract does not state the number of studies or patients included, and does not report the certainty of the evidence.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.